Debates over drug patents are increasingly driven by slogans rather than substance. Claims of “evergreening,” “patent thickets,” and abusive exclusivity are routinely invoked to justify policy ...

Announcing a new article publication for BIO Integration journal. Clinical trials bridge basic research and clinical application, serving as essential steps in drug development. This review examines ...

Clinical trials of a domestic drug for oncological diseases are ongoing in Kazakhstan. According to the Minister of Science ...

Promising cancer drugs often fail in clinical development as early data lack predictive power. This interview explores data ...